Provided by Tiger Fintech (Singapore) Pte. Ltd.

Harmony Biosciences Holdings, Inc.

31.52
-0.3700-1.16%
Volume:138.15K
Turnover:4.40M
Market Cap:1.81B
PE:12.02
High:32.45
Open:32.14
Low:31.43
Close:31.89
Loading ...

Harmony Biosciences presents preclinical data for BP1.15205

TIPRANKS
·
11 Jun

Harmony Biosciences Holdings Inc. Advances Orexin-2 Receptor Agonist BP1.15205 with EMA and FDA Regulatory Filings for First-in-Human Study Planned in 2H 2025

Reuters
·
11 Jun

Mizuho Securities Reaffirms Their Buy Rating on Harmony Biosciences Holdings (HRMY)

TIPRANKS
·
06 Jun

BRIEF-Harmony Biosciences Strengthens Patent Position With Favorable Settlement In ANDA Litigation

Reuters
·
05 Jun

Harmony Biosciences Secures Patent Position with Settlement in WAKIX® Generic Litigation

Reuters
·
05 Jun

Harmony Biosciences Holdings Inc - Settles Patent Litigation With Lupin

THOMSON REUTERS
·
05 Jun

Harmony Biosciences Strengthens Patent Position With Favorable Settlement in Anda Litigation

THOMSON REUTERS
·
05 Jun

Harmony Biosciences Holdings Inc. to Participate in Goldman Sachs Global Healthcare Conference

Reuters
·
04 Jun

Harmony Biosciences Holdings Inc. Conducted Annual Stockholders Meeting

Reuters
·
16 May

Mizuho Raises Price Target on Harmony Biosciences to $48 From $44, Keeps Outperform Rating

MT Newswires Live
·
15 May

Stock Track | Harmony Biosciences Soars 5.04% Following Mixed Analyst Actions

Stock Track
·
08 May

Harmony Biosciences Reports Strong Q1 2025 Results

TIPRANKS
·
07 May

Stock Track | Harmony Biosciences Soars 5.17% on Strong Q1 Results and Reaffirmed 2025 Guidance

Stock Track
·
06 May

Stock Track | Harmony Biosciences Soars 5.17% on Strong Q1 Results and Reaffirmed Guidance

Stock Track
·
06 May

Harmony Biosciences Holdings Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
06 May

BUZZ-Harmony Biosciences rises after quarterly results beat

Reuters
·
06 May

Harmony Biosciences Q1 Adjusted Earnings, Revenue Increase; 2025 Sales Outlook Reiterated

MT Newswires Live
·
06 May

Harmony Biosciences Price Target Maintained With a $49.00/Share by Needham

Dow Jones
·
06 May

Earnings Flash (HRMY) Harmony Biosciences Posts Q1 Revenue $184.7M, vs. FactSet Est of $182.3M

MT Newswires Live
·
06 May

Harmony Biosciences Q1 Adj. EPS $1.03 Beats $0.59 Estimate, Sales $184.73M Beat $182.90M Estimate

Benzinga
·
06 May